COVID-19 vaccine: Johnson & Johnson begins two-dose trial of its vaccine
New York: Drugmaker Johnson & Johnson has launched the Phase 3 trials of the two-dose regimen of its investigational vaccine ...
Read moreDetails
New York: Drugmaker Johnson & Johnson has launched the Phase 3 trials of the two-dose regimen of its investigational vaccine ...
Read moreDetails
By Dilip Cherian The Centre appears keen to give young IPS officers early exposure to the workings and priorities of...
Read moreDetails
The demonstration by scores of policemen and officers outside the Delhi Police headquarters on 2 November to protest against some...
Read moreDetails
More than three years after ethnic violence erupted in Manipur, there is no let-up in the spiral of killings, displacement,...
Read moreDetails
The BJP appears to be clueless as to how to handle the people’s fury and the Opposition’s mega rally at...
Read moreDetails